The NAPLEX, or North American Pharmacist Licensure Examination, is the standardized test that every pharmacist in the United States must pass before they can practice. Since 2004, passing this exam has been a requirement for earning initial pharmacy licensure in all 50 states.1PubMed Central. The NAPLEX: evolution, purpose, scope, and educational implications Administered by the National Association of Boards of Pharmacy (NABP), the NAPLEX is designed to measure whether a pharmacy school graduate has the knowledge and skills expected of someone about to enter practice. The exam’s content, format, and difficulty have changed considerably over the years, and understanding how it works matters whether you are a pharmacy student preparing for it or simply curious about what stands between a PharmD degree and a practicing pharmacist.
Who Needs to Take the NAPLEX
Every graduate of an Accreditation Council for Pharmacy Education (ACPE)-accredited Doctor of Pharmacy (PharmD) program in the United States must pass the NAPLEX as part of the licensure process. The exam is not the only requirement. Most state boards of pharmacy also require candidates to pass the Multistate Pharmacy Jurisprudence Examination (MPJE), which tests knowledge of federal and state pharmacy law. Some states use their own law exams instead. Candidates typically also need to complete a set number of supervised pharmacy practice hours, though the specifics vary by state.
Internationally trained pharmacists follow a different path to NAPLEX eligibility. They generally must first pass the Foreign Pharmacy Graduate Equivalency Examination (FPGEE) with a score of 75 and achieve passing marks on the Test of English as a Foreign Language (TOEFL), with a minimum score of 21 in each of the four sections. Completing both earns them a Foreign Pharmacy Graduate Examination Committee (FPGEC) certificate, which most states accept as part of the application for an intern pharmacist license.2American Journal of Pharmaceutical Education. Process and Performance Outcomes of a Nontraditional Postbaccalaureate PharmD Program Geared Toward Internationally Trained Pharmacists After fulfilling state-mandated internship hours, these candidates become eligible to sit for the NAPLEX alongside their US-trained counterparts.
What the Exam Covers
The NAPLEX blueprint lays out which topics appear on the exam and roughly how much weight each one carries. Historically, the exam organized its content into three broad areas. In an earlier blueprint, those areas were weighted roughly as follows: assessing pharmacotherapy for safe and effective therapeutic outcomes made up about 54 percent of the test, safe and accurate preparation and dispensing of medications accounted for about 35 percent, and assessing and recommending health care information for public health covered about 11 percent.3American Journal of Pharmaceutical Education. An Electronic NAPLEX Review Program for Longitudinal Assessment of Pharmacy Students’ Knowledge
That structure has been substantially revised. The 2025 blueprint introduced new subdomains including immunization, ethics, and mentorship or preceptorship. It also restructured the content by folding previously standalone sections like math and compounding into a broader combined domain with other material, while reducing the share devoted to formulation-related content and increasing the emphasis on clinical knowledge.4PubMed. Evolving Standards: An Examination of NAPLEX Blueprint Changes and Implications for the Academy The shift reflects a broader trend in pharmacy practice: the role of the pharmacist has become increasingly clinical, and the exam is tracking that evolution.
To develop the blueprint, NABP convenes a panel of practicing pharmacists who create a practice analysis document and a set of competency objectives. Those objectives are then validated through a large-scale survey of pharmacists across the country. In the most recent practice analysis, about 1,950 pharmacists provided relevance ratings for the exam’s content domains, and the average rating indicated a high degree of relevance to actual pharmacy practice.5American Journal of Pharmaceutical Education. NAPLEX Practice Analysis and Determining the Knowledge and Skills Expected of an Entry-Level Pharmacist The exam is not designed by academics guessing at what pharmacists need to know; it is shaped by a structured survey of what working pharmacists actually do.
Exam Format and Timing
The NAPLEX is a computer-based exam taken at Pearson VUE testing centers. Candidates have six hours to answer 250 questions, of which 225 are scored and 25 are unscored pretest items being evaluated for potential future use. You have no way of knowing which questions are pretest items, so you need to treat every question as though it counts.
Most questions are multiple choice, but the exam also includes other formats. You may encounter multiple-response questions where more than one answer is correct, ordered-response items where you arrange steps in the right sequence, and constructed-response questions that ask you to type in a calculated value. Many questions are scenario-based, presenting a patient case and asking you to apply clinical reasoning rather than simply recall a fact. The mix of question types is meant to test not just what you know but whether you can use that knowledge in something resembling a real clinical situation.
The exam originally used computer-adaptive testing, in which the difficulty of subsequent questions adjusted based on your earlier answers.1PubMed Central. The NAPLEX: evolution, purpose, scope, and educational implications In more recent iterations, the NAPLEX moved to a fixed-form format, meaning all candidates taking the exam during a given window answer the same set of questions. This shift has implications for scoring and for the consistency of difficulty across test-takers.
How Scoring Works
NAPLEX scores are reported on a scale from 0 to 150, with a passing score of 75. That 75 is not a percentage; it is a scaled score that accounts for the difficulty of the particular set of questions administered. Two candidates answering different versions of the test can both receive comparable scaled scores even if the raw number of correct answers differs slightly, because the scaling process adjusts for variation in item difficulty.
Results are typically available within about seven business days of the test date and are reported to the board of pharmacy in the state where you applied. You receive a pass or fail decision along with your scaled score. If you fail, you also receive a diagnostic report that shows your relative performance across the exam’s content domains, which can guide your study plan for a retake.
When the NAPLEX blueprint underwent a major revision in 2016, there was concern that scores might drop sharply. Research comparing student performance on the old version (2014-2015) with the new version (2016) found that weighted scaled scores did not significantly decline, and the change in pass rates between the two versions was also not statistically significant.6PubMed Central. Comparing Student Performance on the Old vs New Versions of the NAPLEX That finding was reassuring at the time, but the story became more complicated in the years that followed.
Why Pass Rates Have Been Falling
Despite the smooth transition in 2016, longer-term data paint a more sobering picture. A study evaluating NAPLEX performance trends from 2013 through 2025 found that first-time failure odds increased significantly with each successive blueprint revision. Compared to the reference period, the odds of failing on the first attempt roughly doubled under the 2016-2020 blueprint, rose nearly fivefold under the 2021-2024 blueprint, and remained elevated under the 2025 blueprint. The all-attempt odds of failure, meaning the likelihood of failing even after multiple tries, also climbed with each blueprint change.7American Journal of Pharmaceutical Education. The Blueprint Shift: Evaluating NAPLEX and MPJE Performance Trends (2013-2025)
What is driving the decline? The answer is probably not one thing. The expanding clinical focus of the blueprint means that questions increasingly test higher-order reasoning and clinical judgment rather than straightforward recall of drug facts. Students who relied heavily on memorization find the newer versions harder. At the same time, pharmacy school enrollment has expanded significantly over the past two decades, and some educators have raised concerns about whether the average incoming student is as academically prepared as in earlier cohorts. The interaction between a more demanding exam and a broader applicant pool is difficult to disentangle.
The MPJE has seen a similar pattern. First-time odds of failure on the jurisprudence exam rose more than fourfold under its 2016-2023 blueprint and more than fivefold under the 2024-2025 blueprint, suggesting that the challenge is not unique to clinical content but extends to the law exam as well.7American Journal of Pharmaceutical Education. The Blueprint Shift: Evaluating NAPLEX and MPJE Performance Trends (2013-2025) Whatever is making licensure harder, it appears to be a system-wide trend rather than something specific to the NAPLEX alone.
What Predicts Success on the NAPLEX
If you are a pharmacy student wondering what to focus on, the research is fairly clear: your pharmacy school GPA is the single most important predictor of your NAPLEX score. One study examining the association between NAPLEX scores and various pre- and post-admission factors found that pharmacy GPA was the most critical determinant, with the Pre-NAPLEX practice exam score also contributing significantly to the predictive model.8PubMed Central. Examining the Association Between the NAPLEX, Pre-NAPLEX, and Pre- and Post-admission Factors In other words, consistent performance across four years of pharmacy school matters more than cramming in the final weeks.
Academic difficulties during pharmacy school are also a red flag. Research on factors associated with first-attempt pass rates found that students who appeared before an academic standing and promotion review committee during their training were substantially less likely to pass the NAPLEX on their first try. The odds of passing on the first attempt were roughly four and a half times greater for students who had never been called before such a committee.9American Journal of Pharmaceutical Education. Factors Associated with Student Pharmacists’ Academic Progression and Performance on the Licensure Examination That finding makes intuitive sense: students who struggled enough to face a review board had knowledge gaps that persisted into the exam.
What about dedicated NAPLEX preparation programs offered by pharmacy schools? The evidence here is surprisingly underwhelming. A study looking at whether offering a formal prep program was associated with higher first-attempt pass rates found no significant association.10PubMed Central. Association Between NAPLEX Preparation Program Characteristics and First-Time Pass Rates One possible explanation is that students trying to juggle a prep program alongside their final clinical rotations may not get as much out of it as the program designers intended. A follow-up analysis of specific prep program resources found that three commonly required tools, vendor question banks, vendor review books, and live faculty-led review sessions, were each weakly correlated with a decrease in pass rates rather than an increase.11PubMed. NAPLEX Preparation Program Characteristics and Resources Associated With First-Time Exam Pass Rates That does not necessarily mean these resources are harmful. Schools with lower-performing students may be more likely to require them, creating a confounding effect. But the findings do suggest that no commercial prep product is a reliable substitute for a strong foundation built over the full course of pharmacy training.
What Happens If You Do Not Pass
Failing the NAPLEX has real consequences beyond the obvious disappointment. Without a pharmacist license, a graduate cannot practice independently or earn a pharmacist’s salary, yet they are already carrying the student debt that financed their education.12PubMed. Supporting PharmD graduates after unsuccessful licensing examination attempts Pharmacy school is expensive, with many graduates owing well over $150,000, so a delay in licensure translates directly into financial strain.
Retake policies are set by individual state boards of pharmacy, and they vary. Most states allow candidates to retake the NAPLEX after a waiting period, commonly 45 to 90 days after a failed attempt. Many states cap the total number of attempts, often at five, and some impose additional requirements after repeated failures, such as completing additional coursework or supervised practice hours before another attempt is permitted. The NABP itself limits candidates to five attempts within a given state unless the state board grants an exception.
The psychological toll is underappreciated. Pharmacy schools have begun developing support structures for graduates who do not pass, recognizing that the experience can be isolating. Unlike failing a course in school, where support systems and peers are readily available, failing a licensure exam happens after graduation, when the student may no longer have easy access to faculty mentors or study groups. Some schools now offer post-graduation coaching, peer mentorship, and structured review plans aimed specifically at graduates preparing for retakes.
How the NAPLEX Compares Internationally
The NAPLEX is not the only pharmacy licensure exam in the world, but it is among the most studied. A scoping review of how regulatory bodies across different countries determine pharmacists’ readiness for practice identified registration examinations in ten countries. The formats varied widely, including written exams, oral exams, competency-based written assessments, structured clinical examinations, and combinations of these. Written examinations were the most common format across the countries studied.13Research in Social and Administrative Pharmacy. A scoping review of the methods and processes used by regulatory bodies to determine pharmacists’ readiness for practice
One interesting finding from that review is that none of the countries studied provided a formal definition of what “ready to practise” actually means. Every country has an exam, and every exam is built around some notion of minimum competence, but the threshold is essentially set by convention rather than by a universally agreed-upon standard. The NAPLEX’s approach of grounding its blueprint in a large-scale survey of practicing pharmacists is one attempt to anchor that threshold in real-world relevance, though it still involves subjective judgment calls about what topics matter most and how to weight them.
Countries that use oral or clinical-station exams test skills that a written test simply cannot assess, such as patient communication and the ability to physically demonstrate compounding or drug administration techniques. The NAPLEX has added more applied, scenario-based questions over the years, but it remains fundamentally a written exam. Whether written tests alone are sufficient to assess practice readiness is an open question that pharmacy regulators in multiple countries continue to debate.
The Expanding Clinical Emphasis and What It Means for Students
The steady shift toward clinical content on the NAPLEX reflects broader changes in the pharmacy profession itself. Pharmacists in the United States increasingly manage chronic disease states, administer immunizations, adjust medication doses under collaborative practice agreements, and serve as integral members of healthcare teams. The 2025 blueprint’s addition of immunization and ethics subdomains, along with its reduced focus on traditional compounding and formulation, mirrors this evolution.4PubMed. Evolving Standards: An Examination of NAPLEX Blueprint Changes and Implications for the Academy
For pharmacy schools, the blueprint changes create a moving target. Curriculum committees must continually review and adjust what they teach to keep pace with exam content. When clinical content increases, lecture hours on pharmaceutical calculations or compounding may shrink, which creates tension with accreditation standards that still require coverage of those topics. Faculty who have spent careers teaching formulation science find their subjects occupying a smaller share of both the curriculum and the exam.
For students, the practical takeaway is that the NAPLEX increasingly rewards the kind of learning that happens during clinical rotations and patient care experiences, not just the kind that happens in a lecture hall. Understanding how to evaluate a patient’s medication list, identify drug interactions, and recommend therapy changes is now the core of the exam. Memorizing drug brand and generic name pairs still matters, but it is not enough on its own. The students who perform best tend to be the ones who engaged deeply with their clinical rotations and treated them as learning opportunities rather than boxes to check on the way to graduation.